ting Niu, doctor
West China Hospital
7
7
2
N/A
0
5
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+15 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (7)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yongsheng Wang, Doctor
West China Hospital
Shared therapeutic areas:
Worked with same sponsors:
Weili Zhao, Doctor
Ruijin Hospital
Shared therapeutic areas:
Worked with same sponsors:
Wei Yang, Doctor
Shengjing Hospital
Shared therapeutic areas:
Worked with same sponsors:
Zhijian Xiao, Doctor
Hematology Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Lei Zhang, Doctor
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS)
Shared therapeutic areas:
Worked with same sponsors:
Sareeta S Parker, MD
Emory University
Shared therapeutic areas:
Jorge Cortes, MD
UT MD Anderson Cancer Center
Shared therapeutic areas:
Ryotaro Nakamura
City of Hope Medical Center
Shared therapeutic areas:
Will Savage, MD PhD
Disc Medicine
Shared therapeutic areas:
Rami Komrokji, MD
H. Lee Moffitt Cancer Center and Research Institute
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (7)
Showing 7 of 7 trials
Phase IIa Study of Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia Vera
A Phase II Clinical Trial of Flonoltinib Maleate Tablet in Intermediate-High Risk Myelofibrosis
A Phase IIa Clinical Study of Purinostat Mesylate for Injection in Patients With Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative
Study of Purinostat Mesylate for Injection in the Treatment of Relapsed or Refractory B Cell-related Tumor-predominant
All 7 trials loaded